BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38380364)

  • 1. Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.
    Sriramareddy SN; Jamakhani M; Vilanova L; Brossel H; Staumont B; Hamaidia M
    Front Oncol; 2024; 14():1323313. PubMed ID: 38380364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation.
    Gopalakrishnan V; Sharma S; Ray U; Manjunath M; Lakshmanan D; Vartak SV; Gopinatha VK; Srivastava M; Kempegowda M; Choudhary B; Raghavan SC
    Mol Carcinog; 2021 Sep; 60(9):627-643. PubMed ID: 34192388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joining in a Ligase IV dependent manner.
    Vartak SV; Swarup HA; Gopalakrishnan V; Gopinatha VK; Ropars V; Nambiar M; John F; Kothanahally SKS; Kumari R; Kumari N; Ray U; Radha G; Dinesh D; Pandey M; Ananda H; Karki SS; Srivastava M; Charbonnier JB; Choudhary B; Mantelingu K; Raghavan SC
    FEBS J; 2018 Nov; 285(21):3959-3976. PubMed ID: 30230716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of novel SCR7-based small-molecule inhibitor of DNA end-joining, SCR130 and its relevance in cancer therapeutics.
    Ray U; Raul SK; Gopinatha VK; Ghosh D; Rangappa KS; Mantelingu K; Raghavan SC
    Mol Carcinog; 2020 Jun; 59(6):618-628. PubMed ID: 32189406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV.
    Greco GE; Matsumoto Y; Brooks RC; Lu Z; Lieber MR; Tomkinson AE
    DNA Repair (Amst); 2016 Jul; 43():18-23. PubMed ID: 27235626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end-joining.
    Manjunath M; Choudhary B; Raghavan SC
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1341. PubMed ID: 33496064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficiency of homologous recombination and non-homologous end joining systems in repairing double-strand breaks during cell cycle progression.
    Bee L; Fabris S; Cherubini R; Mognato M; Celotti L
    PLoS One; 2013; 8(7):e69061. PubMed ID: 23874869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells.
    Wang H; Zeng ZC; Perrault AR; Cheng X; Qin W; Iliakis G
    Nucleic Acids Res; 2001 Apr; 29(8):1653-60. PubMed ID: 11292837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells.
    Kriger D; Novitskaya K; Vasileva G; Lomert E; Aksenov ND; Barlev NA; Tentler D
    Biol Direct; 2022 Dec; 17(1):40. PubMed ID: 36476259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
    Murmann-Konda T; Soni A; Stuschke M; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer.
    Su X; Liu J; Zhang H; Gu Q; Zhou X; Ji M; Yao D
    Onco Targets Ther; 2020; 13():11183-11192. PubMed ID: 33173310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
    Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity.
    Perona M; Ibañez IL; Thomasz L; Villaverde MS; Oglio R; Rosemblit C; Grissi C; Campos-Haedo M; Dagrosa MA; Cremaschi G; Durán HA; Juvenal GJ
    J Endocrinol Invest; 2023 Nov; 46(11):2353-2365. PubMed ID: 37052871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks.
    Wu L; Shao L; Li M; Zheng J; Wang J; Feng W; Chang J; Wang Y; Hauer-Jensen M; Zhou D
    Radiat Res; 2013 Feb; 179(2):160-70. PubMed ID: 23259762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.
    Gerelchuluun A; Manabe E; Ishikawa T; Sun L; Itoh K; Sakae T; Suzuki K; Hirayama R; Asaithamby A; Chen DJ; Tsuboi K
    Radiat Res; 2015 Mar; 183(3):345-56. PubMed ID: 25738894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors.
    Sergei B; Pavel D; Aigul G; Firyuza B; Ilmira N; Ilshat M; Aida A; Refat K; Natalia A; Elena S; Vera G
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for 53BP1 in the repair of radiation-induced DNA double strand breaks.
    Shibata A; Jeggo PA
    DNA Repair (Amst); 2020 Sep; 93():102915. PubMed ID: 33087281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ligase IV and artemis act cooperatively to suppress homologous recombination in human cells: implications for DNA double-strand break repair.
    Kurosawa A; Saito S; So S; Hashimoto M; Iwabuchi K; Watabe H; Adachi N
    PLoS One; 2013; 8(8):e72253. PubMed ID: 23967291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-ligase IV and DNA-protein kinase play a critical role in deficient caspases activation in apoptosis-resistant cancer cells by using doxorubicin.
    Friesen C; Uhl M; Pannicke U; Schwarz K; Miltner E; Debatin KM
    Mol Biol Cell; 2008 Aug; 19(8):3283-9. PubMed ID: 18508926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
    Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
    Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.